Richtech Robotics Launches Elevator Enabled Robot, Reducing Pharmacist Burnout

Amid a nationwide shortage of pharmacy staff, the company is addressing critical healthcare facility challenges by automating the safe and secure delivery of medications

Richtech Robotics Inc. (Nasdaq: RR) (“Richtech Robotics”), a Nevada company and a provider of AI-driven service robots, today announces the launch of its latest robot: Medbot, an elevator delivery robot designed to streamline pharmacy operations with uninterrupted, 24/7 medications delivery. With high operational accuracy, Medbot improves healthcare facility efficiency with a secure delivery, reducing operating costs and improving the overall patient experience. Medbot furthers Richtech Robotics’ mission of providing high-quality, stable robots to boost employee morale and improve customers’ bottom line.

“At Richtech Robotics, we’re passionate about pioneering solutions to mitigate workplace inefficiencies and build systems that address relevant industry concerns,” said Matt Casella, President of Richtech Robotics. “With a track record of success across the hospitality and service sectors, adapting our products to enhance conditions for the healthcare workforce and infrastructure was a natural progression for us. Finding a way to offload routine daily tasks for healthcare workers has been a pain point for many years, and we’re excited to launch an innovative solution to help hospitals gain a competitive edge.”

The launch of Medbot comes as the healthcare industry faces a concerning dearth of pharmacy staff. With Medbot, hospitals and clinics can automate medication deliveries with reliable, secure and uninterrupted service. Medbot can work up to 24 hours – and 10 hours continuously – making discreet deliveries to patients with high accuracy. In turn, this allows pharmacy technicians to stay stationed in the pharmacy for more important value-add tasks, rather than menial delivery tasks.

Additional product features include:

  • Elevator integration: Ensures reliable, smooth operation across complex spaces.
  • Four storage spaces: Holds up to 3.17 gallons each and can be opened one at a time if desired.
  • Smooth delivery: Works across versatile flooring, helping navigate dense crowds or cluttered spaces.
  • Large touchscreen display: Enables user-friendly, easy delivery scheduling management and real-time visibility.
  • Ultrasonic sensors (8) and cameras (2): Provides heightened obstacle detection and avoidance.
  • IoT enablement: Exchanges data with other devices and systems (e.g. smart doors).

To date, Medbot’s installations have a proven 100% delivery success rate. Medbots have been used in pharmacy to in-patient units and emergency departments, chemotherapy preparations to infusion centers, pharmacy-to-pharmacy/intra-pharmacy transport, and “meds-to-beds” discharge medications from outpatient pharmacy to the patient’s nurse.

“Amid rising operating expenses and a surge in patient numbers across the country, Medbot strives to empower healthcare facilities with superior care, despite staffing shortages. Our Medbot integration method is the only one on the market that has been proven to consistently work,” said Casella.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.